<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267133</url>
  </required_header>
  <id_info>
    <org_study_id>68409</org_study_id>
    <nct_id>NCT04267133</nct_id>
  </id_info>
  <brief_title>Video-based Detection of Atrial Fibrillation</brief_title>
  <official_title>Home-based Videoplethysmographic Detection of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project focuses on the evaluation of a novel, contactless monitoring technology to
      measure the blood pulsatile signal based on the video recording of an individual's face. The
      variability of the pulse rate is computed to identify the presence of atrial fibrillation
      (AF). We propose to enroll 315 patients with symptomatic AF, paroxysmal or persistent, who go
      through successful radiofrequency ablation or electrical cardioversion. A computer tablet
      will be used by the subjects at home during 14 days after their procedure to read emails,
      browse the internet and watch videos. Facial video recordings will be automatically acquired
      during these daily activities by the tablet device. The subject will be wearing an ECG patch
      during the follow-up period. The one-lead continuous ECG will be used as a reference to
      verify the presence of AF rhythm during facial video recordings. The primary aim of the study
      is to demonstrate the validity and robustness of the video-based technology to detect the
      presence of AF when facial videos are acquired by the patients at home.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 24, 2018</start_date>
  <completion_date type="Anticipated">May 24, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 24, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of detection of atrial fibrillation</measure>
    <time_frame>2 weeks</time_frame>
    <description>Number of true atrial fibrillations will be detected using electrocardiogram as a reference. The sensitivity will be calculated as the number of true positives detected by VPG/ total number of subjects with AF determined by electrocardiogram.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean time between VPG detection and reference (ECG detection) of atrial fibrillation</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of detection of atrial fibrillation adjusted for baseline</measure>
    <time_frame>2 weeks</time_frame>
    <description>Sensitivity will be calculated as described in outcome 1 but will be adjusted for baseline information.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">315</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>All Participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Facial video of detection of cardiac disease</intervention_name>
    <description>This project proposes to evaluate a non-contact video recording technology to detect the presence of AF. The technology extracts a pulsatile signal by measuring the subtle variations in skin color of a patient's face (flushing) due to the variations of blood volume underneath the skin. The technology uses a standard web camera. This technique is videoplethysmography (VPG).</description>
    <arm_group_label>All Participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women older than 18 years of age,

          -  Medically-managed for symptomatic AF (persistent or paroxysmal),

          -  In sinus rhythm after their ablation procedure,

          -  In sinus rhythm after trans-thoracic electrical cardioversion.

        Exclusion Criteria:

          -  Implanted with a device (pacemaker, CRT, ICD) and a ventricular pacing requirement
             superior or equal to 70%,

          -  Known allergic reaction to adhesives or hydrogels or with a family history of adhesive
             skin allergies,

          -  Participating in other clinical trials,

          -  Unable to cooperate with the protocol due to dementia, psychological, or other related
             reason,

          -  Refusing to sign the consent for participation,

          -  Unable to operate the device such as blind patients.

          -  Patients with Parkinson disease (or other central nervous system disorder/Tremor) who
             cannot record a stable video signal of their face.

          -  The subject was previously enrolled in the current study.

          -  The subject wears clothing covering the face, or uses facial makeup that will
             interfere with the quality of facial recordings.

          -  Subject does not have internet access at home and lacks the technology to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Philippe Courderc, PhD</last_name>
    <phone>585-275-1096</phone>
    <email>jean-philippe.couderc@heart.rochester.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Strong Memorial Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe D Couderc, PhD</last_name>
      <phone>585-275-1096</phone>
      <email>jean-philippe.couderc@heart.rochester.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 3;119(4):606-18. doi: 10.1161/CIRCULATIONAHA.108.825380.</citation>
    <PMID>19188521</PMID>
  </reference>
  <reference>
    <citation>Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004 Jul;35(7):1647-51. Epub 2004 May 20.</citation>
    <PMID>15155965</PMID>
  </reference>
  <reference>
    <citation>Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D, Jarouse J, Brillman J, Murali S, Gupta R. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008 Nov 18;71(21):1696-701. doi: 10.1212/01.wnl.0000325059.86313.31. Epub 2008 Sep 24.</citation>
    <PMID>18815386</PMID>
  </reference>
  <reference>
    <citation>Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998.</citation>
    <PMID>22236222</PMID>
  </reference>
  <reference>
    <citation>Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014 Jun 26;370(26):2478-86. doi: 10.1056/NEJMoa1313600.</citation>
    <PMID>24963567</PMID>
  </reference>
  <reference>
    <citation>Verkruysse W, Svaasand LO, Nelson JS. Remote plethysmographic imaging using ambient light. Opt Express. 2008 Dec 22;16(26):21434-45.</citation>
    <PMID>19104573</PMID>
  </reference>
  <reference>
    <citation>Couderc JP, Kyal S, Mestha LK, Xu B, Peterson DR, Xia X, Hall B. Detection of atrial fibrillation using contactless facial video monitoring. Heart Rhythm. 2015 Jan;12(1):195-201. doi: 10.1016/j.hrthm.2014.08.035. Epub 2014 Aug 29.</citation>
    <PMID>25179488</PMID>
  </reference>
  <reference>
    <citation>Oral H, Knight BP, Ozaydin M, Tada H, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr, Strickberger SA, Morady F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol. 2002 Jul 3;40(1):100-4.</citation>
    <PMID>12103262</PMID>
  </reference>
  <reference>
    <citation>Lee SH, Tai CT, Hsieh MH, Tsai CF, Lin YK, Tsao HM, Yu WC, Huang JL, Ueng KC, Cheng JJ, Ding YA, Chen SA. Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2004 Jun;10(3):221-6.</citation>
    <PMID>15133358</PMID>
  </reference>
  <reference>
    <citation>Chang SL, Tsao HM, Lin YJ, Lo LW, Hu YF, Tuan TC, Suenari K, Tai CT, Li CH, Chao TF, Lin YK, Tsai CF, Wu TJ, Chen SA. Characteristics and significance of very early recurrence of atrial fibrillation after catheter ablation. J Cardiovasc Electrophysiol. 2011 Nov;22(11):1193-8. doi: 10.1111/j.1540-8167.2011.02095.x. Epub 2011 May 26.</citation>
    <PMID>21615812</PMID>
  </reference>
  <reference>
    <citation>Andrade JG, Khairy P, Verma A, Guerra PG, Dubuc M, Rivard L, Deyell MW, Mondesert B, Thibault B, Talajic M, Roy D, Macle L. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012 Jan;35(1):106-16. doi: 10.1111/j.1540-8159.2011.03256.x. Epub 2011 Nov 6. Review.</citation>
    <PMID>22054110</PMID>
  </reference>
  <reference>
    <citation>Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol. 1996 Sep;28(3):700-6.</citation>
    <PMID>8772759</PMID>
  </reference>
  <reference>
    <citation>Siaplaouras S, Jung J, Buob A, Heisel A. Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion. Europace. 2004 Jan;6(1):15-20.</citation>
    <PMID>14697721</PMID>
  </reference>
  <reference>
    <citation>Yu WC, Lin YK, Tai CT, Tsai CF, Hsieh MH, Chen CC, Hsu TL, Ding YA, Chang MS, Chen SA. Early recurrence of atrial fibrillation after external cardioversion. Pacing Clin Electrophysiol. 1999 Nov;22(11):1614-9.</citation>
    <PMID>10598964</PMID>
  </reference>
  <reference>
    <citation>Møller M, Torp-Pedersen CT, Køber L. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. . Congest Heart Fail. 2001 May-Jun;7(3):146-150.</citation>
    <PMID>11828153</PMID>
  </reference>
  <reference>
    <citation>Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez MV, Freeman JV, Wang PJ, Heidenreich PA. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015 May;38(5):285-92. doi: 10.1002/clc.22387. Epub 2015 Apr 14.</citation>
    <PMID>25873476</PMID>
  </reference>
  <reference>
    <citation>Tung CE, Su D, Turakhia MP, Lansberg MG. Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA. Front Neurol. 2015 Jan 12;5:266. doi: 10.3389/fneur.2014.00266. eCollection 2014.</citation>
    <PMID>25628595</PMID>
  </reference>
  <reference>
    <citation>Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33. doi: 10.1111/pace.12053. Epub 2012 Dec 13.</citation>
    <PMID>23240827</PMID>
  </reference>
  <reference>
    <citation>Chen LY, Agarwal SK, Norby FL, Gottesman RF, Loehr LR, Soliman EZ, Mosley TH, Folsom AR, Coresh J, Alonso A. Persistent but not Paroxysmal Atrial Fibrillation Is Independently Associated With Lower Cognitive Function: ARIC Study. J Am Coll Cardiol. 2016 Mar 22;67(11):1379-80. doi: 10.1016/j.jacc.2015.11.064.</citation>
    <PMID>26988962</PMID>
  </reference>
  <reference>
    <citation>Couderc JP. The Telemetric and Holter ECG Warehouse (THEW): the first three years of development and research. J Electrocardiol. 2012 Nov-Dec;45(6):677-83. doi: 10.1016/j.jelectrocard.2012.08.001. Epub 2012 Sep 28.</citation>
    <PMID>23022305</PMID>
  </reference>
  <reference>
    <citation>Couderc JP. The telemetric and Holter ECG warehouse initiative (THEW): a data repository for the design, implementation and validation of ECG-related technologies. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:6252-5. doi: 10.1109/IEMBS.2010.5628067.</citation>
    <PMID>21097349</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Jean-Philippe Couderc</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

